Subscribe To
turnstone biologics presents preclinical data highlighting potential for selected tumor-infiltrating lymphocyte (til) therapy in solid tumors at the 2023 society for immunotherapy of cancer (sitc) ann
Presentations showcase turnstone’s novel Selected TIL programs which are designed to selectively expa...
November 3, 2023, 10:00 am
turnstone biologics corp. reports second quarter 2023 financial results and provides business update
Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programs Cash position e...
September 1, 2023, 9:57 pm
: turnstone biologics set to go public as upsized $80 million ipo pricing at low end of expected range
turnstone Biologics Corp. TSBX is headed for its public debut Friday, as the San Diego-based biotechnol...
July 21, 2023, 12:20 pm
turnstone biologics set to go public as upsized $80 million ipo pricing at low end of expected range
turnstone Biologics Corp. TSBX, is headed for its public debut Friday, as the San Diego-based biotechno...
July 21, 2023, 8:20 am
turnstone biologics corp. announces pricing of upsized initial public offering
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) — turnstone Biologics Corp. (“...
July 21, 2023, 6:15 am
Ipo update: turnstone biologics readies $75 million ipo plan
turnstone Biologics Corp. has filed proposed terms for a $75.4 million IPO. The firm is developing drug...
July 17, 2023, 3:06 pm
turnstone biologics to offer 5.8 million shares in planned ipo priced at $12 to $14 each
turnstone Biologics TSBX, , a clinical-stage biotech that specializes in treatments for solid tumors, s...
July 17, 2023, 6:35 am